SCHEMBL16634582

SCHEMBL16634582

O=C(O)c1ccc(Nc2ccccc2[N+](=O)[O-])cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.73
ALDH1A1 P00352 3/20 0.73
MAPK1 P28482 2/20 0.73
CASP7 P55210 1/20 0.73
L3MBTL1 Q9Y468 1/20 0.73
HCAR3 P49019 1/20 0.71
KMT2A Q03164 6/20 0.69
MEN1 O00255 5/20 0.69
MAPT P10636 4/20 0.69
GAA P10253 2/20 0.69
PKM P14618 1/20 0.69
AKR1C3 P42330 2/20 0.61
AKR1C2 P52895 2/20 0.61
MYC P01106 1/20 0.58
MAX P61244 1/20 0.58
AURKA O14965 1/20 0.55
GSK3A P49840 1/20 0.55
GSK3B P49841 1/20 0.55
POLB P06746 2/20 0.54
SMN1; SMN2 Q16637 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16634580 1.00 TDP1 (0.73) TDP1ALDH1A1MAPK1CASP7L3MBTL1
SCHEMBL3914644 0.89 MAPK1 (0.71) TDP1ALDH1A1MAPK1CASP7L3MBTL1
SCHEMBL11506844 0.87 ALDH1A1 (0.89) TDP1ALDH1A1MAPK1CASP7L3MBTL1
SCHEMBL11327756 0.86 KMT2A (0.68) TDP1ALDH1A1MAPK1CASP7L3MBTL1
SCHEMBL27481715 0.85 MAPK1 (0.65) TDP1ALDH1A1MAPK1CASP7L3MBTL1
SCHEMBL6677786 0.85 MAPK1 (0.65) TDP1ALDH1A1MAPK1CASP7L3MBTL1
SCHEMBL31333098 0.85 TDP1 (1.00) TDP1ALDH1A1MAPK1CASP7L3MBTL1
SCHEMBL230292 0.85 TDP1 (1.00) TDP1ALDH1A1MAPK1CASP7L3MBTL1
SCHEMBL30839074 0.84 AKR1C3 (0.72) TDP1ALDH1A1MAPK1CASP7L3MBTL1
SCHEMBL3497986 0.84 MAPT (0.64) TDP1ALDH1A1MAPK1CASP7L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015052675-A1 SUBSTITUTED DIHYDRO-BENZIMIDAZOLE COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2015-04-16 WO disclosed